Ayyappan JP, Abraham A. Targeting TLR4/MAPKs signaling pathway: A better option for therapeutic inhibition of atherosclerosis. World J Immunol 2014; 4(2): 116-121 [DOI: 10.5411/wji.v4.i2.116]
Please LOGIN to submit a new comment.